These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 24276244)
1. Selective roles of E2Fs for ErbB2- and Myc-mediated mammary tumorigenesis. Wu L; de Bruin A; Wang H; Simmons T; Cleghorn W; Goldenberg LE; Sites E; Sandy A; Trimboli A; Fernandez SA; Eng C; Shapiro C; Leone G Oncogene; 2015 Jan; 34(1):119-28. PubMed ID: 24276244 [TBL] [Abstract][Full Text] [Related]
2. Transcription factor compensation during mammary gland development in E2F knockout mice. To B; Andrechek ER PLoS One; 2018; 13(4):e0194937. PubMed ID: 29617434 [TBL] [Abstract][Full Text] [Related]
3. Specific tumor suppressor function for E2F2 in Myc-induced T cell lymphomagenesis. Opavsky R; Tsai SY; Guimond M; Arora A; Opavska J; Becknell B; Kaufmann M; Walton NA; Stephens JA; Fernandez SA; Muthusamy N; Felsher DW; Porcu P; Caligiuri MA; Leone G Proc Natl Acad Sci U S A; 2007 Sep; 104(39):15400-5. PubMed ID: 17881568 [TBL] [Abstract][Full Text] [Related]
4. A role for E2F activities in determining the fate of Myc-induced lymphomagenesis. Rempel RE; Mori S; Gasparetto M; Glozak MA; Andrechek ER; Adler SB; Laakso NM; Lagoo AS; Storms R; Smith C; Nevins JR PLoS Genet; 2009 Sep; 5(9):e1000640. PubMed ID: 19749980 [TBL] [Abstract][Full Text] [Related]
6. HER2/Neu tumorigenesis and metastasis is regulated by E2F activator transcription factors. Andrechek ER Oncogene; 2015 Jan; 34(2):217-25. PubMed ID: 24362522 [TBL] [Abstract][Full Text] [Related]
7. Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity. Cicchini M; Chakrabarti R; Kongara S; Price S; Nahar R; Lozy F; Zhong H; Vazquez A; Kang Y; Karantza V Autophagy; 2014; 10(11):2036-52. PubMed ID: 25483966 [TBL] [Abstract][Full Text] [Related]
8. Silencing of E2F3 suppresses tumor growth of Her2+ breast cancer cells by restricting mitosis. Lee M; Oprea-Ilies G; Saavedra HI Oncotarget; 2015 Nov; 6(35):37316-34. PubMed ID: 26512919 [TBL] [Abstract][Full Text] [Related]
9. Myc and mammary cancer: Myc is a downstream effector of the ErbB2 receptor tyrosine kinase. Hynes NE; Lane HA J Mammary Gland Biol Neoplasia; 2001 Jan; 6(1):141-50. PubMed ID: 11467449 [TBL] [Abstract][Full Text] [Related]
10. The nuclear receptor coactivator amplified in breast cancer-1 is required for Neu (ErbB2/HER2) activation, signaling, and mammary tumorigenesis in mice. Fereshteh MP; Tilli MT; Kim SE; Xu J; O'Malley BW; Wellstein A; Furth PA; Riegel AT Cancer Res; 2008 May; 68(10):3697-706. PubMed ID: 18483252 [TBL] [Abstract][Full Text] [Related]
11. Protein tyrosine kinase 6 promotes ERBB2-induced mammary gland tumorigenesis in the mouse. Peng M; Ball-Kell SM; Tyner AL Cell Death Dis; 2015 Aug; 6(8):e1848. PubMed ID: 26247733 [TBL] [Abstract][Full Text] [Related]
12. Cyclin F Controls Cell-Cycle Transcriptional Outputs by Directing the Degradation of the Three Activator E2Fs. Clijsters L; Hoencamp C; Calis JJA; Marzio A; Handgraaf SM; Cuitino MC; Rosenberg BR; Leone G; Pagano M Mol Cell; 2019 Jun; 74(6):1264-1277.e7. PubMed ID: 31130363 [TBL] [Abstract][Full Text] [Related]
14. The E2F transcription factors regulate tumor development and metastasis in a mouse model of metastatic breast cancer. Hollern DP; Honeysett J; Cardiff RD; Andrechek ER Mol Cell Biol; 2014 Sep; 34(17):3229-43. PubMed ID: 24934442 [TBL] [Abstract][Full Text] [Related]
15. Prediction and genetic demonstration of a role for activator E2Fs in Myc-induced tumors. Fujiwara K; Yuwanita I; Hollern DP; Andrechek ER Cancer Res; 2011 Mar; 71(5):1924-32. PubMed ID: 21245101 [TBL] [Abstract][Full Text] [Related]
16. Myc requires distinct E2F activities to induce S phase and apoptosis. Leone G; Sears R; Huang E; Rempel R; Nuckolls F; Park CH; Giangrande P; Wu L; Saavedra HI; Field SJ; Thompson MA; Yang H; Fujiwara Y; Greenberg ME; Orkin S; Smith C; Nevins JR Mol Cell; 2001 Jul; 8(1):105-13. PubMed ID: 11511364 [TBL] [Abstract][Full Text] [Related]
17. Myc is required for β-catenin-mediated mammary stem cell amplification and tumorigenesis. Moumen M; Chiche A; Decraene C; Petit V; Gandarillas A; Deugnier MA; Glukhova MA; Faraldo MM Mol Cancer; 2013 Oct; 12(1):132. PubMed ID: 24171719 [TBL] [Abstract][Full Text] [Related]
18. E2f1, E2f2, and E2f3 control E2F target expression and cellular proliferation via a p53-dependent negative feedback loop. Timmers C; Sharma N; Opavsky R; Maiti B; Wu L; Wu J; Orringer D; Trikha P; Saavedra HI; Leone G Mol Cell Biol; 2007 Jan; 27(1):65-78. PubMed ID: 17167174 [TBL] [Abstract][Full Text] [Related]
19. Control of the p53-p21CIP1 Axis by E2f1, E2f2, and E2f3 is essential for G1/S progression and cellular transformation. Sharma N; Timmers C; Trikha P; Saavedra HI; Obery A; Leone G J Biol Chem; 2006 Nov; 281(47):36124-31. PubMed ID: 17008321 [TBL] [Abstract][Full Text] [Related]
20. Division and apoptosis of E2f-deficient retinal progenitors. Chen D; Pacal M; Wenzel P; Knoepfler PS; Leone G; Bremner R Nature; 2009 Dec; 462(7275):925-9. PubMed ID: 20016601 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]